---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297199765.md"
description: "NeuroOne Medical Technologies shares are trading higher after the company announced it has completed three separate large-animal procedures using its next-generation StereoCED platform."
datetime: "2026-08-27T14:03:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297199765.md)
  - [en](https://longbridge.com/en/news/297199765.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297199765.md)
generator: "portal-rs"
---

# 

NeuroOne Medical Technologies shares are trading higher after the company announced it has completed three separate large-animal procedures using its next-generation StereoCED platform.

### Related Stocks

- [NMTC.US](https://longbridge.com/en/quote/NMTC.US.md)

## Related News & Research

- [NeuroOne reports successful large-animal procedures using next-generation StereoCED platform](https://longbridge.com/en/news/297191400.md)
- [NeuroOne Advances StereoCED Toward Human Clinical Studies](https://longbridge.com/en/news/297210429.md)
- [Neuroone Medical Technologies Corp - Announces Successful Robotic-Assisted Drug Delivery Using Stereoced Platform - SEC Filing](https://longbridge.com/en/news/297194419.md)
- [PAHC: Strong sales and EBITDA growth driven by Animal Health, with positive FY2027 outlook](https://longbridge.com/en/news/297189527.md)
- [16:22 ETAirvet and HABRI Partner to Advance the Human-Animal Bond](https://longbridge.com/en/news/297558124.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**